Literature DB >> 16274965

Development of functional thymic epithelial cells occurs independently of lymphostromal interactions.

William E Jenkinson1, Simona W Rossi, Eric J Jenkinson, Graham Anderson.   

Abstract

The thymus provides a specialised microenvironment for the development of T-cell precursors. This developmental programme depends upon interactions with stromal cells such as thymic epithelial cells, which provide signals for proliferation, survival and differentiation. In turn, it has been proposed that development of thymic epithelial cells themselves is regulated by signals produced by developing thymocytes. Evidence in support of this symbiotic relationship, termed thymic crosstalk, comes from studies analysing the thymus of adult mice harbouring blocks at specific stages of thymocyte development, where it is difficult to separate mechanisms regulating the initial development of thymic epithelial cells from those regulating their maintenance. To distinguish between these processes, we have analysed the initial developmental programme of thymic epithelial cells within the embryonic thymus, in either the presence or absence of normal T-cell development. We show that keratin 5+8+ precursor epithelial cells present in the early thymic rudiment differentiate into discrete cortical and medullary epithelial subsets displaying normal gene expression profiles, and acquire functional competence, independently of signals from T-cell precursors. Thus, our findings redefine current models of thymus development and argue against a role for thymocyte-epithelial cell crosstalk in the development of thymic epithelial progenitors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16274965     DOI: 10.1016/j.mod.2005.08.003

Source DB:  PubMed          Journal:  Mech Dev        ISSN: 0925-4773            Impact factor:   1.882


  8 in total

Review 1.  Strategies for reconstituting and boosting T cell-based immunity following haematopoietic stem cell transplantation: pre-clinical and clinical approaches.

Authors:  Ann P Chidgey; Natalie Seach; Jarrod Dudakov; Maree V Hammett; Richard L Boyd
Journal:  Semin Immunopathol       Date:  2008-11-04       Impact factor: 9.623

Review 2.  Greater than the sum of their parts: combination strategies for immune regeneration following allogeneic hematopoietic stem cell transplantation.

Authors:  Jarrod A Dudakov; Marcel R M van den Brink
Journal:  Best Pract Res Clin Haematol       Date:  2011-06-29       Impact factor: 3.020

Review 3.  The thymus and the immune system: layered levels of control.

Authors:  Diana K Lee; Frances T Hakim; Ronald E Gress
Journal:  J Thorac Oncol       Date:  2010-10       Impact factor: 15.609

Review 4.  The immunopathology of thymic GVHD.

Authors:  Werner Krenger; Georg A Holländer
Journal:  Semin Immunopathol       Date:  2008-10-31       Impact factor: 9.623

5.  Modulation of Aire regulates the expression of tissue-restricted antigens.

Authors:  Vivian Kont; Martti Laan; Kai Kisand; Andres Merits; Hamish S Scott; Pärt Peterson
Journal:  Mol Immunol       Date:  2007-06-28       Impact factor: 4.407

6.  Requirement of Stat3 Signaling in the Postnatal Development of Thymic Medullary Epithelial Cells.

Authors:  Rumi Satoh; Kiyokazu Kakugawa; Takuwa Yasuda; Hisahiro Yoshida; Maria Sibilia; Yoshimoto Katsura; Ben Levi; Jakub Abramson; Yoko Koseki; Haruhiko Koseki; Willem van Ewijk; Georg A Hollander; Hiroshi Kawamoto
Journal:  PLoS Genet       Date:  2016-01-20       Impact factor: 5.917

Review 7.  A Tale from TGF-β Superfamily for Thymus Ontogeny and Function.

Authors:  Arnon Dias Jurberg; Larissa Vasconcelos-Fontes; Vinícius Cotta-de-Almeida
Journal:  Front Immunol       Date:  2015-09-10       Impact factor: 7.561

8.  Intrathymic injection of hematopoietic progenitor cells establishes functional T cell development in a mouse model of severe combined immunodeficiency.

Authors:  Andrea Z Tuckett; Raymond H Thornton; Richard J O'Reilly; Marcel R M van den Brink; Johannes L Zakrzewski
Journal:  J Hematol Oncol       Date:  2017-05-16       Impact factor: 17.388

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.